Miyamoto S, Heerspink HJL, de Zeeuw D, Sakamoto K, et al. A randomized, open-label, clinical trial examined the effects of canagliflozin on albuminuria and eGFR decline using an individual pre-intervention eGFR slope. Kidney Int 2024;106:972-984.
PMID: 39216659